About VIRION THERAPEUTICS LLC
Virion Therapeutics is a clinical-stage biopharmaceutical company developing novel T cell-based immunotherapies for cancer and chronic infectious diseases. Their lead program, VRON-0200, has completed a Phase 1b trial showing durable anti-HBV activity in chronic HBV-infected patients.
Development of T cell-based immunotherapiesUtilization of proprietary checkpoint modifiersCreation of disease-specific CD8+ T cell-based immunotherapiesViral vector platform for antigen delivery
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to VIRION THERAPEUTICS LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.